The GO enrichment analysis of DMR showed that the GO terms were significantly enriched in neurotransmitter transporter activity, neurotransmitter: sodium symporter and organic acid: sodium symporter activity, which was related to the pathogenesis of MG (Fig. 5A). This evidence concerns the gene SLC6A2 and myasthenia gravis.